View profile

🦠My Financial Times opinion piece: "Why AI has disappointed on Covid"

Revue
 
include state of ai
 

Your guide to AI

September 20 · Issue #45 · View online
Monthly analysis of AI technology, geopolitics, research, and startups.

include state of ai

The Financial Times, September 20th 2020
Opinion | Artificial intelligence 
Why AI has disappointed on Covid 
BY NATHAN BENAICH 
The writer is a biologist, general partner of Air Street Capital and co-author of State of AI Report 
In late February, an artificial intelligence algorithm created by MIT researchers made front-page news for discovering a powerful new antibiotic that could save millions of lives by treating drug-resistant diseases. Yet for many people, what was notable about the moment was that it wasn’t surprising: we have become accustomed to a steady drumbeat of AI breakthroughs. 
Just three weeks later, the World Health Organization declared Covid-19 a pandemic. Geeks around the world sprang into action. A company called C3.ai compiled data sets for AI researchers to crunch. The AI-first drug discovery company Recursion released a morphological image data set of Covid-19 infected cells as they react to thousands of drugs. DeepMind used its AlphaFold AI system to predict and publish structures associated with coronavirus. 
AI seemed on track to crush the new pathogen, just as it mastered the ancient Chinese board game Go. And then — nothing. 
At a time when we expect AI to solve most problems — since that has been the industry promise for years — why has it been so ineffective in the fight against the biggest global crisis in a generation? 
There are inherent limitations to AI today. […] 

If you’re not already a subscriber to the FT – or other media sources such as NYT, WSJ, The Economist, etc – I encourage you to join in order to support substantive journalism when we need it most.
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue